Company news
Co-Diagnostics, Inc. news in 2020
Co-Diagnostics, Inc.'s news releases, calls and decks from 2020, newest first.
Co-Diagnostics Announces Milestone of Over 10 Million COVID-19 Tests Sold
December 13, 2020
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test
November 24, 2020
Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Tests
November 16, 2020
Co-Diagnostics, Inc. Announces Q3 2020 Financial Results Including YTD Net Income per Common Share of $1.07
November 15, 2020
Co-Diagnostics, Inc. CoPrimers™ Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction
November 10, 2020
Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings Webcast
November 9, 2020
Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share
November 1, 2020
Co-Diagnostics, Inc. Provides Update on "ABC" Test for Influenza A, Influenza B, and COVID-19
September 23, 2020
Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services
September 7, 2020
Co-Diagnostics, Inc. Issues Operational Update
August 31, 2020
Co-Diagnostics, Inc. Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test
August 19, 2020
Co-Diagnostics, Inc. Announces Q2 2020 Results on Form 10-Q
August 12, 2020
Co-Diagnostics, Inc. Announces Q2 2020 Earnings Release Date and Earnings Webcast
August 10, 2020
Co-Diagnostics, Inc. Logix Smart™ COVID-19 Test Authorized for Use in Australia
August 6, 2020
Co-Diagnostics, Inc. Technology to be Used in FDA-Authorized Self-Collected COVID-19 Saliva Test
August 2, 2020
Co-Diagnostics, Inc. to Join Russell 2000® and Russell 3000® Indexes
June 8, 2020
Co-Diagnostics, Inc. Announces Q1 2020 Results and Provides Mid-Second Quarter Update
May 13, 2020
Co-Diagnostics, Inc. Announces Q1 2020 Earnings Release Date and Earnings Call
May 11, 2020
Co-Diagnostics, Inc. Announces Government Approvals and Increased Orders for COVID-19 Test Kits
May 3, 2020
Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations
April 30, 2020
Co-Diagnostics, Inc. Announces Expansion of COVID-19 Test Orders in the United States
April 19, 2020
Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples
April 15, 2020
Co-Diagnostics, Inc. Contracts with Promega Corp for COVID-19 Test Manufacturing as Company Expands Domestic Customer Base
April 13, 2020
Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test
April 5, 2020
Co-Diagnostics, Inc. Reports 2019 Year-End Financial Results and Progress Updates
March 30, 2020
Co-Diagnostics, Inc Completes Successful Clinical Evaluation Required for FDA Emergency Use Authorization
March 19, 2020
Co-Diagnostics JV CoSara First Indian Company to Receive License for COVID-19 Diagnostic
March 18, 2020
Co-Diagnostics, Inc. Reports Additional Demand for Coronavirus Test Shipments
March 4, 2020
Co-Diagnostics Announces Closing of $4.2 Million Registered Direct Offering Priced At-the-Market
March 1, 2020
Co-Diagnostics Announces $4.2 Million Registered Direct Offering Priced At-the-Market
February 26, 2020
Co-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus Test
February 23, 2020
Co-Diagnostics Completes Submission of CE Marking Registration for COVID-19 Coronavirus Test
February 19, 2020
Co-Diagnostics Announces New Vector Control Orders and Continued Progress Toward Regulatory Clearance for Coronavirus Test
February 18, 2020
Co-Diagnostics Announces $10.2 Million Registered Direct Offering Priced At-the-Market
February 10, 2020
Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test
February 9, 2020
Co-Diagnostics, Inc. Announces Launch of Test for New Coronavirus
February 5, 2020
Co-Diagnostics, Inc. Announces Successful Initial Verification of Novel Coronavirus Test
January 30, 2020
Co-Diagnostics Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market
January 27, 2020
Co-Diagnostics Announces $5.0 Million Registered Direct Offering Priced At-the-Market
January 23, 2020
Co-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ Platform
January 22, 2020